INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 281 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,132,998 | +107.4% | 112,650 | +77.4% | 0.99% | +106.0% |
| Q1 2023 | $3,439,067 | -43.3% | 63,510 | -44.5% | 0.48% | -42.0% |
| Q4 2022 | $6,061,139 | +54.0% | 114,534 | +35.4% | 0.83% | +57.4% |
| Q3 2022 | $3,936,000 | -79.0% | 84,584 | -74.2% | 0.53% | -79.3% |
| Q2 2022 | $18,716,000 | +9.9% | 327,894 | +17.8% | 2.54% | +32.9% |
| Q1 2022 | $17,035,000 | +3478.8% | 278,395 | +2170.8% | 1.91% | +166.4% |
| Q2 2016 | $476,000 | – | 12,260 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |